Trials / Completed
CompletedNCT01081483
A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults
A Blinded, Randomized, Placebo-controlled Phase 1 Study in Healthy Male Adults to Evaluate the Safety, Tolerability and Pharmacokinetic Profiles of Single Doses of ABT-072
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Abbott · Industry
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of blinded, single ascending oral doses of ABT 072 under non-fasting conditions in healthy adult Japanese male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABT-072 | See arm description for more information |
| DRUG | Placebo | See arm description for more information |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-06-01
- First posted
- 2010-03-05
- Last updated
- 2010-10-25
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01081483. Inclusion in this directory is not an endorsement.